1 / 5

Baseline characteristics of study sample by lipid-modifying drug class

Baseline characteristics of study sample by lipid-modifying drug class. Sachin J. Kamal-Bahl, et al. Am J Cardiol 2007;99:530–534. Estimation of probability of continuation of LMD therapy by class over time. Sachin J. Kamal-Bahl, et al. Am J Cardiol 2007;99:530–534.

harken
Download Presentation

Baseline characteristics of study sample by lipid-modifying drug class

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Baseline characteristics of study sample by lipid-modifying drug class Sachin J. Kamal-Bahl, et al. Am J Cardiol 2007;99:530–534

  2. Estimation of probability of continuation of LMD therapy by class over time Sachin J. Kamal-Bahl, et al. Am J Cardiol 2007;99:530–534

  3. Unadjusted and adjusted hazard ratios from Cox regression for discontinuation of lipid-modifying drugs Sachin J. Kamal-Bahl, et al. Am J Cardiol 2007;99:530–534

  4. Adjusted cumulative incidence (95% confidence interval) of discontinuation at 12, 18, and 24 months by lipid-modifying drug class Sachin J. Kamal-Bahl, et al. Am J Cardiol 2007;99:530–534

  5. Adjusted hazard ratios and cumulative incidence of discontinuation over 12 months by lipid-modifying drug class in subgroup analysis of patients with coronary heart disease and diabetes Sachin J. Kamal-Bahl, et al. Am J Cardiol 2007;99:530–534

More Related